Business Wire: Swing Therapeutics Announces Positive Results from Studies of Stanza, a Digital Therapeutic for Fibromyalgia Treatment Swing Therapeutics Announces Positive Results from Studies of Stanza, a Digital Therapeutic for Fibromyalgia Treatment The American Journal of Managed Care: TNX-102 SL Now Fourth FDA-Approved Treatment for Fibromyalgia TNX-102 SL is the first new fibromyalgia treatment approved in over 15 years, joining three other treatments. Phase 3 trials showed significant pain reduction and good tolerance, with improvements in ... NeuroMetrix made headlines—and history—earlier this year as it secured the FDA’s first clearance for a non-drug fibromyalgia treatment and laid out a plan to begin rolling out the wearable ...
Seeking Alpha: Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year Healio: Research suggests treatment of fibromyalgia should be tailored to individual symptoms Nasdaq: Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
